Tag: Metastatic Breast Cancer
July 3, 2018
4 Top Biotech Stocks on the TSX of Q2 2018
Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of... June 25, 2018
Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE in HR+, HER2- Metastatic Breast Cancer
Pfizer (NYSE:PFE) today announced overall survival (OS) results from the Phase 3 PALOMA-3 trial, which evaluated IBRANCE® (palbociclib) in combination with... April 26, 2018
Merus Announces Recent Corporate Developments and Financial Results for the Fourth Quarter and Full Year 2017
Merus (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced financial results for the fourth quarter... April 3, 2018
BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal
BriaCell Therapeutics Corp. ("BriaCell") (TSXV:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to... March 27, 2018
BriaCell Completes Previously Announced Oversubscribed Non-Brokered Private Placement and Concurrent Investment With Leading U.S. Biotech Funds
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSXV:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology,...
March 19, 2018
What is Oncology Investing?
What is oncology investing? This sector can be intimidating for investors first getting into the space — here's a brief breakdown... March 8, 2018